Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.20.2
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2020
Investments All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents As of September 30, 2020, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

43,289

 

 

$

 

 

$

43,289

 

 

$

43,289

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

11,026

 

 

 

 

 

 

11,026

 

 

 

11,026

 

Total

 

$

54,315

 

 

$

 

 

$

54,315

 

 

$

54,315

 

 

As of December 31, 2019, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

23,710

 

 

$

 

 

$

23,710

 

 

$

23,710

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

20,355

 

 

 

 

 

 

20,355

 

 

 

20,355

 

Total

 

$

44,065

 

 

$

 

 

$

44,065

 

 

$

44,065

 

Summary of Quantitative Information with Respect to Significant Inputs

The following table summarizes quantitative information with respect to the significant inputs that were used to value the 2020 Stock Warrants during the nine months ended September 30, 2020:

 

 

Compensation Warrant

 

 

Performance Warrant

 

Volatility

 

88

%

 

 

85

%

Risk-free rate

 

0.23

%

 

 

0.34

%

Term

1.7 years

 

 

3.7 years